Analysis of the efficacy and safety of bortezomib for treating newly diagnosed multiple myeloma through different administration methods

BACKGROUND: This study aims to compare the efficacy and adverse reactions of bortezomib for treating newly diagnosed multiple myeloma (MM) through two different administration methods: intravenous (IV) injection and subcutaneous (SC) injection. METHODS: A retrospective analysis was performed in 205...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong-Mei, Liu, Xi-Yang, Liu, Yu-Zhang, Liu, Li-Na, Lin, Quan-De, Song, Yong-Ping, Fang, Bai-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749981/
https://www.ncbi.nlm.nih.gov/pubmed/31571987
http://dx.doi.org/10.2147/CMAR.S218979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749981/
https://www.ncbi.nlm.nih.gov/pubmed/31571987
http://dx.doi.org/10.2147/CMAR.S218979

Ejemplares similares